BioSpace News Archive

ViewRay, Inc. (NASDAQ: VRAY) today announced that GenesisCare has entered into a master purchase agreement for up to 14 MRIdian® MR-Guided Therapy Systems, immediately expanding programs in United Kingdom (UK) and Ft. Myers, Florida.

Tegria today announced the acquisition of KenSci, a leader in artificial intelligence platforms and applications for healthcare, with roots in Microsoft’s Azure4Research program and the University of Washington .

PANTHERx ® Rare Pharmacy announced today that it was selected by Rhythm Pharmaceuticals as the exclusive U.S. pharmacy distribution partner for IMCIVREE ™ (setmelanotide).

Vivera Pharmaceuticals, Inc., is pleased to welcome Mr. Gonçalo Leal to the Scientific Advisory Board of the Company’s Neurosciences Division.

Synaptogenix, Inc. today announced that Dr. Daniel Alkon , the Company’s President and Chief Scientific Officer, will appear as a featured guest on TD Ameritrade Network’s “The Watch List” on Friday, June 25, 2021 at 1:20 pm ET

Personal Genome Diagnostics Inc. (PGDx) today announced a strategic collaboration with Massachusetts General Hospital (MGH).

Treatment With Hepcludex ® (Bulevirtide) Was Shown to Achieve Significant Response in Chronic Hepatitis Delta Virus After 24 Weeks

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to provide an update on the status of key initiatives:

New treatments for liver disease patients have been given top billing at this week’s International Liver Congress (ILC), one of the biggest global meetings for liver doctors and researchers, including technologies being developed by Yaqrit Discovery Ltd (‘Yaqrit’ or the ‘Company’), a UK life sciences company developing treatments for patients with cirrhosis and its complications, an area of global unmet medical need.

Otolith Labs, launched at the Halcyon Incubator, announced today it has received U.S. Food and Drug Administration (FDA) BREAKTHROUGH DEVICE designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo